메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
백아람 (부산대학교) 한솔아 (The University of Texas) 김시인 (경희대학교) 서혜선 (경희대학교)
저널정보
한국보건의료기술평가학회 보건의료기술평가 보건의료기술평가 제10권 제2호
발행연도
2022.12
수록면
84 - 88 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: To compare sociopolitical responses of countries about N-nitrosodimethylamine (NDMA). Methods: We searched websites of regulatory authorities of six countries (i.e., US, Europe, Australia, Japan, Taiwan, and Korea) without on date or language. We used search term including NDMA, valsartan, ranitidine, nizatidine, metformin. Comparison was conducted by a predetermined analysis frame including damage scales (i.e., number of recalled drugs) and responses by regulatory authorities/manufacturers/patients/health care professionals. Results: The number of products is the largest in Korea. The responses by countries were similar. Regulatory authorities provided a list of recalled drugs and NDMA detection test method. In addition, they assessed theoretical risk and investigate cause of NDMA impurity. Manufacturers performed NDMA test to products and recalled product exceeding the acceptable standard of NDMA. Patients were requested to continue taking medicine without consultation with health care professionals. In Europe, Australia and Taiwan, no nizatidine and metformin product exceeded the standard of NDMA. Conclusion: We hope the results of our study may serve as an important basis for studies that establish the response procedures for NDMA impurities. In addition, to respond appropriately to the NDMA impurities, a compensation system will be also needed and further research is inevitable in this area.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0